ASH 2011 Conference Coverage

Novel drug safe for patients with leukemia

Results of a phase I clinical trial showed that a new drug targeting mitochondrial function in human cancer cells was safe and showed some efficacy in a heavily pretreated cohort of patients.

IMPRESS study shows continuing tyrosine kinase inhibitors after progression not effective

Patients with non-small cell lung cancer and resistance to gefitinib do not experience any significant improvement with gefitinib.

Aspirin may decrease the risk for developing high-grade prostate cancer

Aspirin and other other NSAIDs were associated with a decreased risk for developing an aggressive form of prostate cancer.

Studying Cancer Treatment in the Elderly Patient Population

Age has in impact on the biology of cancer, treatment goals, and barriers to treatment. Older patients are also currently under-represented in clinical trials, but this need not be the case.

No association found between wearing a bra and breast cancer

A recent study found no link between bra wearing and increased breast cancer risk among postmenopausal women.

Once-weekly breast radiation regimen improves on current treatment

An experimental regimen of once-weekly breast irradiation after lumpectomy provides more convenience to patients at less expense, and results in better completion rates of prescribed radiation treatment.

Reconstituting nab-paclitaxel

Is there a good reason to mix nab-paclitaxel (Abraxane) with warm (not cool) normal saline when reconstituting?

Women under 30 not recognizing signs of cervical cancer

Many women under 30 years of age do not recognize the symptoms of cervical cancer.

For colorectal adenomas, biennial screening increases diagnosis rates

Screening patients biennially for colorectal cancer increased the rate of diagnosis of high-risk polyps by 89%.

Facing prostate cancer—but not alone

Frank dela Rama, a new member of the Oncology Nurse Advisor editorial board, talks about helping men with newly diagnosed prostate cancer learn about and prepare to cope with their disease.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs